https://www.selleckchem.com/pr....oducts/bay-1895344-h
4 ug/L [95% CI -69.4, 0.53] vs. 0.35 ug/L [95% CI -3.8, 4.5], p=.08), but the difference was not statistically significant. No significant differences were observed in changes from baseline of D-dimer, inflammatory, and endothelial activation markers or measures of microvascular blood flow. Rivaroxaban was well tolerated. Rivaroxaban was safe but did not significantly decrease coagulation activation, endothelial activation, or inflammation. Rivaroxaban did not improve microvascular blood flow. Adequately powered studies are requ
Like
Comment
Share
